	Clinical features and prognostic factors of ovarian cancer brain metastases from ovarian cancer: a retrospective multicenter study of 129 cases. BMC Cancer Wang Y, Chao Q, Lu X, Zhou Y, Xie Z, Zhang S, Xu F, Wu S, Hu L, Ding B, Zhang X, Xu T, Ni G, Liang J, Zhou J, Shen Y, Yang B, Zhou S, Chen X, Shi T, Lan C, Zhu T, Zhou Y. PMID: 41204125 [PubMed - as supplied by publisher]
	Integrative single-cell and bulk RNA-seq analysis identifies glycosyltransferases-related signature in triple negative breast cancer. Funct Integr Genomics Hu J, Yuan N, Huang Z, Liu Y, Tu B, Yu X, Hui T, Zuo G. PMID: 41203941 [PubMed - in process]
	Co-clinical trial targeting ER, FGFR and CDK4/6 in resistant hormone-positive breast cancer with FGFR alterations. NPJ Precis Oncol Martinez-Jañez N, García-Saenz JÁ, Pernas S, Bermejo B, Morales S, Guerra J, Silva J, Manso L, Ciruelos E, Tolosa P, Sánchez-Bayona R, Alva M, Calabuig-Fariñas S, Gallach S, Muinelo-Romay L, Piñeiro-Yáñez E, Caleiras E, Bueno MJ, Mouron S, Quintela-Fandino M. PMID: 41203797 [PubMed]
	Efficacy and toxicity of post-neoadjuvant trastuzumab emtansine in HER2-positive breast cancer patients treated at Institut Curie Hospitals. Sci Rep De Moura A, Gleizes O, Cabel L, Bethune-Volters A, Bellesoeur A, Bello-Roufai D, Cottu P, Sebbag C, Loirat D, Geiss R, Pierga JY, Escalup L, Bidard FC, Genevée T. PMID: 41203771 [PubMed - indexed for MEDLINE]
	Trace element imbalances in selenium and mercury in relation to mammographic density and breast cancer progression: a caseâ€’control study. Sci Rep Unar A, Chanihoon GQ, Bashir MS, Alredah IA, Qureshi M, Ataya FS, Ali A, Alsawalha L, Afridi HI. PMID: 41203703 [PubMed - indexed for MEDLINE]
	Prevalence and prognosis of extra-capsular extension in isolated lymph nodal recurrence from ovarian cancer: the ECEROC study. Int J Gynecol Cancer Bruno M, Santoro A, Arrigo D, Lopopolo G, Zannoni GF, Costantini B, Gallotta V, Fagotti A. PMID: 41203528 [PubMed - as supplied by publisher]
	[Breast cancer in men: a rare condition that needs to be better understood]. Soins Darmon I. PMID: 41203370 [PubMed - indexed for MEDLINE]
	KMT2C mutations in breast cancer: molecular mechanisms of cancer promotion, clinical significance, and potential as biomarkers. Crit Rev Oncol Hematol Hsu MC, Chen YF, Yamaguchi H. PMID: 41203099 [PubMed - as supplied by publisher]
	Beyond AJCC Staging: A Socioeconomic-Clinical Nomogram for Predicting 10-Year Survival in Epithelial Ovarian Cancer. J Obstet Gynaecol Can Zhao J, Xie S, Cheng Q, Jin W, Zhu H. PMID: 41203014 [PubMed - as supplied by publisher]
	Comparing [(18)F]FDG-positron emission tomography and breast magnetic resonance imaging to predict pathological complete response and 3-year invasive disease-free survival in HER2-positive early breast cancer patients: an unplanned exploratory analysis of the PHERGain trial. ESMO Open García-Mosquera JJ, Pérez-García JM, Ruiz-Borrego M, Stradella A, Bermejo B, Escrivá-de-Romaní S, Calvo Martínez L, Gebhart G, Kerrou K, Gion M, Antonarelli G, Santasusagna Canal S, Rodríguez-Morato J, Mina L, Sampayo-Cordero M, Llombart-Cussac A, Cortés J. PMID: 41202503 [PubMed - as supplied by publisher]
	Zanidatamab in combination with docetaxel in first-line HER2-positive breast cancer: results from an open-label, multicenter, phase Ib/II study. ESMO Open Wang X, Lee KS, Zeng X, Sun T, Im YH, Li H, Wang K, Zhou P, Li V, Chen S, Jiang Z. PMID: 41202501 [PubMed - as supplied by publisher]
	Exploring PIPAC for managing platinum resistant and refractory ovarian cancer with peritoneal spread: A collaborative multi-institutional study. Eur J Surg Oncol Tesei M, Scarpelli E, Giudice MT, Costantini B, Fiuzzi E, Coada CA, Salutari V, Mezzapesa F, Fagotti A, De Iaco P, Vizzielli G, Perrone AM. PMID: 41202433 [PubMed - as supplied by publisher]
	Causal effects of telomere length on ovarian tumor risk: Insights from genetic evidence. J Chromatogr B Analyt Technol Biomed Life Sci Lang T, Liang X, Yang Y. PMID: 41202422 [PubMed - as supplied by publisher]
	Corrigendum to 'OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer' [Gynecol Oncol 2025 Jun 197 182-191]. Gynecol Oncol Thaker PH, Richardson DL, Hagemann AR, Holloway RW, Reed M, Bergman MK, Pothuri B, DePasquale S, Scalici JM, Bregar AJ, Darus CJ, Finkelstein K, Leath CA 3rd, Bell M, Warshal DP, Agajanian R, Indermaur MD, Mendivil AA, Provencher DM, Wei LJ, Borys N, Musso L, Lindborg SR, Faller DV, Anwer K, Bradley WH. PMID: 41202407 [PubMed - as supplied by publisher]
	Multi-omics study of prognostic models and molecular networks related to ovarian cancer. Discov Oncol Bian P, Liu S, Zhang W, Luo Q, Xiong Z. PMID: 41201568 [PubMed]
	Targeting the LINC00265/miR-485-5p axis for diagnosis and therapeutic intervention in breast cancer. Discov Oncol Jiang Q, Han S, Chang R, Pan J, Zhang B. PMID: 41201488 [PubMed]
	Bidirectional Association Between Atrial Fibrillation and Ovarian Cancer: Evidence From the UK Biobank and Mendelian Randomization. Cancer Epidemiol Biomarkers Prev Zhang Z, Zhang N, Guo X, Tao Z, Wu C, Liu Q, Ding L, Chen W, Zhong Y, Jiang M, Pu J. PMID: 41201259 [PubMed - as supplied by publisher]
	Relationship of Body Mass Index and Dietary Inflammatory Index With Free Androgen Index and Insulin Resistance in Women With Polycystic Ovary Syndrome. Int J Vitam Nutr Res Ghanbarzadeh N, Hajizadeh K, Farshbaf-Khalili A, Mahdipour M, Shahnazi M. PMID: 41201221 [PubMed - indexed for MEDLINE]
	Immune system, inflammatory response, and regulated cell death in breast cancer research (Review). Oncol Rep Li G, Jin B, Zhou J, Fang S, Fan Z. PMID: 41201017 [PubMed - indexed for MEDLINE]
	Study assesses normal tissue effects after axillary radiotherapy for early breast cancer. CA Cancer J Clin Printz C. PMID: 41200965 [PubMed - in process]

Articles 1 - 20 / 317079

Page 1 of 15854



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy